4.6 Article

Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 175, Issue 3, Pages 539-544

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2014.06.039

Keywords

Cell therapy; Chronic ischemia; Bone marrow cell; Intramyocardial injection

Funding

  1. Translational Regenerative Medicine [SSM06004]
  2. Netherlands Organization for Health Research and Development (ZonMW) [11.600.1016]
  3. Boston Scientific
  4. Medtronic
  5. Biotronik
  6. BioMedical Materials [SMARTCARE] program
  7. Translational Adult Stem Cell (TAS) program [11.600.1016]

Ask authors/readers for more resources

Background: We previously showed that intramyocardial bone marrow cell (BMC) injection in patients with refractory angina and chronic myocardial ischemia improves myocardial perfusion, cardiac function and disease-related complaints. Treatment effect varied between patients, but the predictors of response remain to be identified. Therefore, the aim of the present study was to assess whether patient characteristics, procedural data and baseline measurements influence the response to intramyocardial BMC treatment in a large cohort of refractory angina patients. Methods and results: In 120 patients (64 +/- 9 years, 88% men) with refractory angina, 97 +/- 13 x 10(6) BMCs were injected intramyocardially in regions with stress-inducible ischemia as assessed by single photon emission computed tomography (SPECT). Canadian Cardiovascular Society angina (CCS) class, quality-of-life score, exercise testing, SPECT and magnetic resonance imaging were performed at baseline and at 3 months follow-up demonstrating significant improvements in CCS class, quality-of-life, exercise capacity, myocardial perfusion and left ventricular function (all variables P < 0.001). Multivariate analysis was performed to evaluate the influence of patient characteristics, procedural data and baseline measurements on BMC treatment response. Based on the improvement of myocardial perfusion at stress, diabetes and a large number of ischemic segments at baseline were shown to be independently associated with a large response to BMC therapy. Conclusion: The present study demonstrates that diabetes and a large number of ischemic segments are predictors of a large response to intramyocardial BMC injection in refractory angina and chronic ischemia. Furthermore, the safety and efficacy results of previous trials are now confirmed in a larger study population. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy

Sebastiaan R. Piers, Alexander F. Androulakis, Kevin S. Yim, Nienke van Rein, Jeroen Venlet, Gijsbert F. Kapel, Hans-Marc Siebelink, Hildo J. Lamb, Suzanne C. Cannegieter, Sum-Che Man, Katja Zeppenfeld

Summary: This study found that spontaneous nonsustained ventricular tachycardia (NSVT) on Holter and VT inducibility during electrophysiology study can independently predict sustained ventricular arrhythmias (SVA) during follow-up in patients with nonischemic dilated cardiomyopathy (DCM). NSVT may serve as an initiator, while sustained VT inducibility indicates the presence of the substrate for SVA in DCM.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2022)

Article Hematology

Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy

Yassene Mohammed, Carolina E. Touw, Banne Nemeth, Raymond A. van Adrichem, Christoph H. Borchers, Frits R. Rosendaal, Bart J. van Vlijmen, Suzanne C. Cannegieter

Summary: This study explores the potential of using protein levels in blood plasma to predict venous thrombosis (VT) risk. The researchers identified specific proteins that were associated with VT development and used a logistic regression model to accurately predict VT risk.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Inter- and intra-individual concentrations of direct oral anticoagulants: The KIDOAC study

Myrthe M. A. Toorop, Nienke van Rein, Melchior C. Nierman, Helga W. Vermaas, Menno Huisman, Felix J. M. van der Meer, Suzanne C. Cannegieter, Willem M. Lijfering

Summary: The study found that the inter-individual variability of DOAC concentrations was higher than intra-individual variability, and lower previous VKA dosage and creatinine clearance were associated with higher DOAC trough concentrations.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

Cathrine Ramberg, Kristian Hindberg, Joseph S. Biedermann, Suzanne C. Cannegieter, Felix J. van der Meer, Omri Snir, Frank W. G. Leebeek, Marieke J. H. A. Kruip, John-Bjarne Hansen, Willem M. Lijfering

Summary: The study investigated the impact of rosuvastatin treatment on plasma PPL activity and extracellular vesicle (EV) levels. The results showed that rosuvastatin treatment led to a substantial decrease in plasma PPL activity.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Editorial Material Hematology

The interplay between GPIb/IX antibodies, platelet hepatic sequestration, and TPO levels in patients with chronic ITP

Sufia N. Amini, Vivianne S. Nelson, Leendert Porcelijn, Tanja Netelenbos, Jaap Jan Zwaginga, Masja de Haas, Martin R. Schipperus, Rick Kapur

Summary: ITP is an autoimmune bleeding disorder characterized by platelet clearance in the spleen and liver. Thrombopoietin (TPO) levels remain low in ITP. The role of GPIb antibodies in relation to platelet hepatic sequestration and TPO levels in ITP remains unclear. This study found a positive association between GPIb antibodies and TPO levels as well as platelet hepatic sequestration in patients with severe thrombocytopenic ITP.

BLOOD ADVANCES (2023)

Article Hematology

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease

Astrid G. S. van Halteren, Jessica S. Suwandi, Sander Tuit, Jelske Borst, Sandra Laban, Roula Tsonaka, Ada Struijk, Anna-Sophia Wiekmeijer, Melissa van Pel, Bart O. Roep, Jaap Jan Zwaginga, Arjan C. Lankester, Koen Schepers, Maarten J. D. van Tol, Willem E. Fibbe

Summary: Acute graft-versus-host disease (aGVHD) is a potentially fatal complication of stem cell transplantation. This study used mass cytometry to analyze the immune cells in children with severe aGVHD and compared the results with control groups. The onset of aGVHD was associated with the appearance of specific myeloid and lymphoid cells in the blood and affected organs such as the skin and gastrointestinal tract. The findings highlight the importance of immune cell profiling for evaluating clinical response and managing severe aGVHD.

BLOOD (2023)

Article Infectious Diseases

Original Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial

Arvind Gharbharan, Carlijn Jordans, Lisa Zwaginga, Grigorios Papageorgiou, Nan van Geloven, Peter van Wijngaarden, Jan den Hollander, Faiz Karim, Elena van Leeuwen-Segarceanu, Robert Soetekouw, Jolanda Lammers, Douwe Postma, Linda Kampschreur, Geert Groeneveld, Francis Swaneveld, C. Ellen van der Schoot, Hannelore Gotz, Bart Haagmans, Marion Koopmans, Susanne Bogers, Corine Geurtsvankessel, Jaap Jan Zwaginga, Casper Rokx, Bart Rijnders

Summary: This study aimed to determine the effectiveness of convalescent plasma therapy in high-risk outpatients with COVID-19. The results showed that convalescent plasma therapy did not improve the disease severity score.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Hematology

Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma

Fleur H. J. Kaptein, Milou A. M. Stals, Richard E. Evenhuis, Hans Gelderblom, Menno V. Huisman, Diederik S. A. Karis, Renee W. D. Noten, Suzanne C. Cannegieter, Frank M. Speetjens, Arjan J. Verschoor, Henri H. Versteeg, Michiel A. J. van de Sande, Frederikus A. Klok

Summary: Patients with osteosarcoma and Ewing sarcoma have a high risk of venous thromboembolism, especially in patients aged 18 and above. Catheter-related upper-extremity thrombosis is the most frequent presentation of venous thromboembolism. Major bleeding is common in both types of sarcoma.

THROMBOSIS RESEARCH (2023)

Article Hematology

Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study

Maaike Y. Kapteijn, Fleur H. J. Kaptein, Milou A. M. Stals, Eva E. Klaase, Ronald van Eijk, Dina Ruano, Sjoerd G. van Duinen, Suzanne C. Cannegieter, Martin J. B. Taphoorn, Linda Dirven, Johan A. F. Koekkoek, Frederikus A. Klok, Henri H. Versteeg, Jeroen T. Buijs, Ines Garcia-Ortiz

Summary: This study suggests a potential role for CDKN2A deletion in glioblastoma-related VTE, providing a potential predictive marker for this population.

THROMBOSIS RESEARCH (2023)

Article Immunology

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From 5 Randomized Trials

Adam C. Levine, Yuriko Fukuta, Moises A. Huaman, Jiangda Ou, Barry R. Meisenberg, Bela Patel, James H. Paxton, Daniel F. Hanley, Bart J. A. Rijnders, Arvind Gharbharan, Casper Rokx, Jaap Jan Zwaginga, Andrea Alemany, Oriol Mitja, Dan Ouchi, Pere Millat-Martinez, Valerie Durkalski-Mauldin, Frederick K. Korley, Larry J. Dumont, Clifton W. Callaway, Romina Libster, Gonzalo Perez Marc, Diego Wappner, Ignacio Esteban, Fernando Polack, David J. Sullivan

Summary: COVID-19 convalescent plasma treatment can reduce the risk of hospitalization, especially when administered within 5 days of symptom onset and with higher antibody titers.

CLINICAL INFECTIOUS DISEASES (2023)

Review Physiology

Hemoglobin modulation affects physiology and patient reported outcomes in anemic and non-anemic subjects: An umbrella review

R. P. B. Tonino, L. M. Zwaginga, M. R. Schipperus, J. J. Zwaginga

Summary: Abnormal hemoglobin concentration significantly affects a person's quality of life and physiology. Current tools for evaluating hemoglobin-related outcomes are lacking, leading to uncertainty in optimal hemoglobin levels and treatment targets. Reviews show that increasing hemoglobin improves patient-reported and physical outcomes, particularly at lower hemoglobin levels. However, there is a lack of high-quality evidence in this area.

FRONTIERS IN PHYSIOLOGY (2023)

Article Medicine, Research & Experimental

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis

Laura F. Ouboter, Marieke C. Barnhoorn, Hein W. Verspaget, Leonie Plug, Emma S. Pool, Karoly Szuhai, Lukas J. A. C. Hawinkels, Melissa van Pel, Jaap Jan Zwaginga, Dave Roelen, Frits Koning, M. Fernanda Pascutti, Andrea E. van der Meulen-de Jong

Summary: A phase IIa clinical study evaluated the impact of local mesenchymal stromal cell (MSC) therapy on ulcerative proctitis (UP), and found it to be safe, feasible, and showed encouraging signs of clinical efficacy and modulation of local immune responses.

JCI INSIGHT (2023)

Article Cardiac & Cardiovascular Systems

Leucocyte and platelet activation in cardiac surgery patients with and without lung injury: A prospective cohort study

Judith Van Paassen, Alice De Graaf-Dijkstra, Anja H. Brunsveld-Reinders, Evert De Jonge, Robert J. M. Klautz, Roula Tsonaka, Jaap Jan Zwaginga, M. Sesmu Arbous

Summary: Acute lung injury after cardiac surgery is associated with an unfavorable outcome. Prior to surgery, cardiac surgery patients who developed lung injury showed higher platelet activatability and indications for higher neutrophil turnover. Further research is needed to determine the relationship between these factors and the development of lung injury after cardiac surgery.

INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY (2023)

Article Multidisciplinary Sciences

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageourgiou, Nan van Geloven, Carlijn Jordans, Geert Groeneveld, Francis Swaneveld, Ellen van der Schoot, Marc Corbacho-Monne, Dan Ouchi, Francini Piccolo Ferreira, Pierre Malchair, Sebastian Videla, Vanesa Garcia Garcia, Anna Ruiz-Comellas, Anna Ramirez-Morros, Joana Rodriguez Codina, Rosa Amado Simon, Joan-Ramon Grifols, Julian Blanco, Ignacio Blanco, Jordi Ara, Quique Bassat, Bonaventura Clotet, Barbara Baro, Andrea Troxel, Jaap Jan Zwaginga, Oriol Mitja, Bart J. A. Rijnders

Summary: This study assessed whether convalescent plasma (CP) administered during the first week of symptoms reduced disease progression or risk of hospitalization in COVID-19 outpatients. The results showed that CP had no significant impact on disease severity scale and hospitalization or death, but may have some effect in patients with symptoms lasting <= 5 days. Additionally, CP did not shorten the time to full symptom resolution.

NATURE COMMUNICATIONS (2022)

Meeting Abstract Hematology

Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis

R. J. S. Anijs, Q. Chen, W. M. Lijfering, S. C. Cannegieter

THROMBOSIS RESEARCH (2022)

No Data Available